Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

NCT00610597 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2008-02-08

No results posted yet for this study

Summary

Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (CD4+ T cell secreting Interleukin-17) Th17 pathway is involved in alcoholic liver disease.

Conditions

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Arnaud Lemmers, MD · Erasme Hospital, Gastroenterology Dpt

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-01-31
Completion
2008-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610597 on ClinicalTrials.gov